Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Guanylin activates Cl(-) secretion into the lumen of seawater eel intestine via apical Cl(-) channel under simulated in vivo conditions.

Ando M, Takei Y.

Am J Physiol Regul Integr Comp Physiol. 2015 Mar 1;308(5):R400-10. doi: 10.1152/ajpregu.00333.2014. Epub 2014 Dec 24.

PMID:
25540100
2.

Hypertonic saline releases the attached small intestinal cystic fibrosis mucus.

Ermund A, Meiss LN, Scholte BJ, Hansson GC.

Clin Exp Pharmacol Physiol. 2015 Jan;42(1):69-75. doi: 10.1111/1440-1681.12322.

3.

[Inhaled treatments in cystic fibrosis: what's new in 2013?].

Dubus JC, Bassinet L, Chedevergne F, Delaisi B, Desmazes-Dufeu N, Reychler G, Vecellio L; GRAM (Groupe aérosols et mucoviscidose de la Société française de mucoviscidose).

Rev Mal Respir. 2014 Apr;31(4):336-46. doi: 10.1016/j.rmr.2013.12.001. Epub 2014 Jan 4. Review. French.

PMID:
24750953
4.

[Non-cystic fibrosis bronchiectasis [corrected]].

Ringshausen FC, Rademacher J, Welte T.

Dtsch Med Wochenschr. 2014 Apr;139(14):707-10. doi: 10.1055/s-0034-1369837. Epub 2014 Mar 25. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2014 Apr;139(14):e9.

PMID:
24668431
5.

Hypertonic saline for cystic fibrosis: worth its salt?

Goralski JL, Donaldson SH.

Expert Rev Respir Med. 2014 Jun;8(3):267-9. doi: 10.1586/17476348.2014.896203. Epub 2014 Mar 26.

PMID:
24666113
6.

Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients.

Michon AL, Jumas-Bilak E, Chiron R, Lamy B, Marchandin H.

PLoS One. 2014 Feb 28;9(2):e90164. doi: 10.1371/journal.pone.0090164. eCollection 2014.

7.

Role of mucolytics in wet cough.

Dhar R.

J Assoc Physicians India. 2013 May;61(5 Suppl):23-7. Review. No abstract available.

PMID:
24490447
8.

Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel.

Peled O, Kalamaro V, Kerem E, Shoseyov D, Blau H, Efrati O, Block C.

J Cyst Fibros. 2014 Sep;13(5):550-6. doi: 10.1016/j.jcf.2014.01.001. Epub 2014 Jan 28.

PMID:
24484849
9.

Modifying disease in cystic fibrosis: current and future therapies on the horizon.

Ong T, Ramsey BW.

Curr Opin Pulm Med. 2013 Nov;19(6):645-51. doi: 10.1097/MCP.0b013e328365ab5f. Review.

PMID:
24048086
10.

Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.

Rasgado-Flores H, Krishna Mandava V, Siman H, Van Driessche W, Pilewski JM, Randell SH, Bridges RJ.

Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1114-22. doi: 10.1152/ajpcell.00166.2013. Epub 2013 Aug 28.

12.

Early intervention for newborns screened for cystic fibrosis.

Beydon N, Robinson PD.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):409-10. doi: 10.1164/rccm.201306-1023ED. No abstract available.

PMID:
23947515
13.

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A.

Cochrane Database Syst Rev. 2013 Jul 12;7:CD007168. doi: 10.1002/14651858.CD007168.pub3. Review.

PMID:
23852992
14.

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

Snijders D, Calgaro S, Bertozzi I, Quartesan S, Kozuh I, Lunardi F, Barbato A.

Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):529-34. Review.

PMID:
23755770
15.

Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.

Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.

J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):133-7. doi: 10.1089/jamp.2012.1034. Epub 2013 Jun 8.

PMID:
23745525
16.

Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):456-60. doi: 10.1164/rccm.201302-0219OC.

17.

Update in cystic fibrosis 2012.

Goss CH, Ratjen F.

Am J Respir Crit Care Med. 2013 May 1;187(9):915-9. doi: 10.1164/rccm.201301-0184UP. Review. No abstract available.

PMID:
23634859
18.

Nebuliser systems for drug delivery in cystic fibrosis.

Daniels T, Mills N, Whitaker P.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD007639. doi: 10.1002/14651858.CD007639.pub2. Review.

PMID:
23633344
19.

Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance.

Cresta F, Naselli A, Favilli F, Casciaro R.

BMJ Case Rep. 2013 Apr 29;2013. pii: bcr2013009042. doi: 10.1136/bcr-2013-009042.

20.

Cystic fibrosis papers of the year 2012.

Doull I.

Paediatr Respir Rev. 2013 May;14 Suppl 1:28-30. doi: 10.1016/j.prrv.2013.02.006. Epub 2013 Feb 26. Review.

PMID:
23452761
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk